series-c-plus
Stage
2018
Founded
2
Investors
About
iPSC platform developing next generation NK cell and macrophage-cell therapies
Explore Shoreline Biosciences's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.